GeoVax Labs (GOVX) had the highest return between September 1, 2019 and December 30, 2019 by a US stock, returning 1,297,197.3%.
| ASSET | DATE | % RETURN |
|---|---|---|
GeoVax Labs (GOVX) | 9/1/2019 - 12/30/2019 | 1,297,197.3% |
Weatherford International (WFRD) | 9/1/2019 - 12/30/2019 | 93,737.88% |
DarioHealth (DRIO) | 9/1/2019 - 12/30/2019 | 1,270.45% |
Nextplat (NXPL) | 9/1/2019 - 12/30/2019 | 1,213.04% |
Sobr Safe (SOBR) | 9/1/2019 - 12/30/2019 | 896.92% |
Kodiak Sciences (KOD) | 9/1/2019 - 12/30/2019 | 572.55% |
Agape ATP Corporation Common Stock (ATPC) | 9/1/2019 - 12/30/2019 | 560% |
Oncolytics Biotech (ONCY) | 9/1/2019 - 12/30/2019 | 545% |
Battalion Oil (BATL) | 9/1/2019 - 12/30/2019 | 524.5% |
Clearside Biomedical (CLSD) | 9/1/2019 - 12/30/2019 | 447.37% |
Cassava Sciences (SAVA) | 9/1/2019 - 12/30/2019 | 432.17% |
Pennant (PNTG) | 9/1/2019 - 12/30/2019 | 415.28% |
Kiora Pharmaceuticals (KPRX) | 9/1/2019 - 12/30/2019 | 397.96% |
FuelCell Energy (FCEL) | 9/1/2019 - 12/30/2019 | 380% |
Axsome Therapeutics (AXSM) | 9/1/2019 - 12/30/2019 | 310.88% |
Castellum (CTM) | 9/1/2019 - 12/30/2019 | 285.71% |
Relmada Therapeutics (RLMD) | 9/1/2019 - 12/30/2019 | 280.84% |
Aurinia Pharmaceuticals (AUPH) | 9/1/2019 - 12/30/2019 | 253.23% |
Neurogene (NGNE) | 9/1/2019 - 12/30/2019 | 251.81% |
Matinas BioPharma (MTNB) | 9/1/2019 - 12/30/2019 | 216.23% |
Aprea Therapeutics (APRE) | 9/1/2019 - 12/30/2019 | 212.1% |
Lexicon Pharmaceuticals (LXRX) | 9/1/2019 - 12/30/2019 | 206.67% |
Immunitybio (IBRX) | 9/1/2019 - 12/30/2019 | 193.13% |
Avadel Pharmaceuticals (AVDL) | 9/1/2019 - 12/30/2019 | 189.6% |
Quince Therapeutics (QNCX) | 9/1/2019 - 12/30/2019 | 183.63% |
